Clinical Trials Directory

Trials / Completed

CompletedNCT07004426

Symptomatic and Incidental RCC Detection

Assessment of Symptomatic and Incidental Detection of Renal Cell Carcinoma Using Standard Imaging Modalities

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Charles University, Czech Republic · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the frequency of symptomatic and incidental detection of renal carcinoma at different stages depending on the imaging modality used

Detailed description

In the Czech Republic, there is no screening program for renal cell carcinoma. Existing evidence suggests that incidental detection of this cancer tends to occur in its early stages, which are more manageable due to effective treatment options, ultimately reducing renal cancer mortality. This highlights the potential value of evaluating current imaging modalities and determining their role in secondary prevention. This cross-sectional study, based on hospital data, aims to contribute to a better understanding of this issue and to assess the effectiveness of imaging techniques in the early detection of renal cell carcinoma. Furthermore, data analysis may reveal the influence of risk factors on the detection of tumors at various stages.

Conditions

Interventions

TypeNameDescription
PROCEDURESurgical treatment of renal lesionsSurgical treatment of renal lesions

Timeline

Start date
2025-06-01
Primary completion
2025-07-01
Completion
2025-07-15
First posted
2025-06-04
Last updated
2026-03-19

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT07004426. Inclusion in this directory is not an endorsement.